Vaccinex, Inc. (NASDAQ:VCNX – Get Free Report) shares traded up 26.3% during mid-day trading on Friday . The stock traded as high as $1.11 and last traded at $0.78. 5,025 shares changed hands during trading, an increase of 62% from the average session volume of 3,109 shares. The stock had previously closed at $0.62.
Vaccinex Stock Up 26.3%
The firm has a market cap of $2.04 million, a P/E ratio of -0.02 and a beta of 1.10. The firm has a fifty day moving average of $0.80 and a 200-day moving average of $0.84.
About Vaccinex
Vaccinex, Inc, a clinical-stage biotechnology company, engages in the discovery and development of targeted biotherapeutics to treat cancer, neurodegenerative diseases, and autoimmune disorders. The company's lead drug candidate, pepinemab, a humanized monoclonal antibody that binds and blocks the activity of SEMA4D.
Recommended Stories
- Five stocks we like better than Vaccinex
- There Are Different Types of Stock To Invest In
- 3 Restaurant Stocks That Will Outperform in Q3 and Q4
- Investing in Commodities: What Are They? How to Invest in Them
- The Midstream Energy Play That Keeps Powering Higher
- What is the Shanghai Stock Exchange Composite Index?
- Ethereum Near All-Time High: 3 Stocks Stacking ETH in Treasuries
Receive News & Ratings for Vaccinex Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Vaccinex and related companies with MarketBeat.com's FREE daily email newsletter.
-logo-1200x675.jpg?v=20220728163351&h=45&w=95&zc=2){kind=logo}